BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18065788)

  • 1. Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study.
    Melamed ML; Eustace JA; Plantinga LC; Jaar BG; Fink NE; Parekh RS; Coresh J; Yang Z; Cantor T; Powe NR
    Nephrol Dial Transplant; 2008 May; 23(5):1650-8. PubMed ID: 18065788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated parathyroid hormone predicts mortality in dialysis patients undergoing valve surgery.
    Yan H; Sharma J; Weber CJ; Guyton RA; Perez S; Thourani VH
    Surgery; 2011 Dec; 150(6):1095-101. PubMed ID: 22136827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.
    Kaczirek K; Prager G; Riss P; Wunderer G; Asari R; Scheuba C; Bieglmayer C; Niederle B
    Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
    Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients.
    Guh JY; Chen HC; Chuang HY; Huang SC; Chien LC; Lai YH
    Am J Kidney Dis; 2002 Jun; 39(6):1245-54. PubMed ID: 12046038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.
    Danese MD; Kim J; Doan QV; Dylan M; Griffiths R; Chertow GM
    Am J Kidney Dis; 2006 Jan; 47(1):149-56. PubMed ID: 16377396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vitamin C on parathyroid hormone in hemodialysis patients with mild to moderate secondary hyperparathyroidism.
    Sanadgol H; Bayani M; Mohammadi M; Bayani B; Mashhadi MA
    Iran J Kidney Dis; 2011 Nov; 5(6):410-5. PubMed ID: 22057074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are PTH serum levels predictive of coronary calcifications in haemodialysis patients?
    Coen G; Manni M; Mantella D; Pierantozzi A; Balducci A; Condò S; DiGiulio S; Yancovic L; Lippi B; Manca S; Morosetti M; Pellegrino L; Simonetti G; Gallucci MT; Splendiani G
    Nephrol Dial Transplant; 2007 Nov; 22(11):3262-7. PubMed ID: 17597083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.
    Block GA; Klassen PS; Lazarus JM; Ofsthun N; Lowrie EG; Chertow GM
    J Am Soc Nephrol; 2004 Aug; 15(8):2208-18. PubMed ID: 15284307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High third generation/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation/second generation PTH ratio in patients with primary hyperparathyroidism.
    Caron P; Maiza JC; Renaud C; Cormier C; Barres BH; Souberbielle JC
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):533-8. PubMed ID: 18782355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study.
    Naves-Díaz M; Passlick-Deetjen J; Guinsburg A; Marelli C; Fernández-Martín JL; Rodríguez-Puyol D; Cannata-Andía JB
    Nephrol Dial Transplant; 2011 Jun; 26(6):1938-47. PubMed ID: 20513773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical significance of parathyroid tissue calcium sensing receptor gene polymorphisms and expression levels in end-stage renal disease patients.
    Eren PA; Turan K; Berber I; Canbakan M; Kara M; Tellioglu G; Bugan U; Sevinç C; Turkmen F; Titiz MI
    Clin Nephrol; 2009 Aug; 72(2):114-21. PubMed ID: 19640368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between whole and intact parathyroid hormone assays.
    Taniguchi M; Tanaka M; Hamano T; Nakanishi S; Fujii H; Kato H; Koiwa F; Ando R; Kimata N; Akiba T; Kono T; Yokoyama K; Shigematsu T; Kakuta T; Kazama JJ; Tominaga Y; Fukagawa M
    Ther Apher Dial; 2011 Jun; 15 Suppl 1():42-9. PubMed ID: 21595852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary hyperparathyroidism in patients on maintenance hemodialysis.
    Hida M
    Tokai J Exp Clin Med; 1982 Nov; 7(6):665-70. PubMed ID: 7184198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
    Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
    Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of quick bio-intact PTH(1-84) assay during parathyroidectomy for secondary hyperparathyroidism.
    Ikeda Y; Kurihara H; Morita N; Miyabe R; Takami H
    J Surg Res; 2007 Aug; 141(2):306-10. PubMed ID: 17418873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intact whole bioactive parathormone: problems arising from comparing different methods].
    Marangella M; Migliardi M; Dutto F; Mengozzi G; Marranca D; Bagnis C; Berutti S; Gallone G; Aimo G; Ramello A; Fonzo D
    G Ital Nefrol; 2002; 19(4):467-75. PubMed ID: 12369051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineral metabolism and mortality in dialysis patients: a reassessment of the K/DOQI guideline.
    Noordzij M; Korevaar JC; Dekker FW; Boeschoten EW; Bos WJ; Krediet RT; Bossuyt PM; Geskus RB;
    Blood Purif; 2008; 26(3):231-7. PubMed ID: 18305386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.